260 related articles for article (PubMed ID: 17681762)
1. A detailed examination of cytokine abnormalities in Major Depressive Disorder.
Simon NM; McNamara K; Chow CW; Maser RS; Papakostas GI; Pollack MH; Nierenberg AA; Fava M; Wong KK
Eur Neuropsychopharmacol; 2008 Mar; 18(3):230-3. PubMed ID: 17681762
[TBL] [Abstract][Full Text] [Related]
2. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
[TBL] [Abstract][Full Text] [Related]
3. Cytokine imbalance in the pathophysiology of major depressive disorder.
Kim YK; Na KS; Shin KH; Jung HY; Choi SH; Kim JB
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1044-53. PubMed ID: 17433516
[TBL] [Abstract][Full Text] [Related]
4. The Role of Chemokines in the Pathophysiology of Major Depressive Disorder.
Milenkovic VM; Stanton EH; Nothdurfter C; Rupprecht R; Wetzel CH
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31075818
[TBL] [Abstract][Full Text] [Related]
5. Pericardial adipose tissue and the metabolic syndrome is increased in patients with chronic major depressive disorder compared to acute depression and controls.
Kahl KG; Herrmann J; Stubbs B; Krüger TH; Cordes J; Deuschle M; Schweiger U; Hüper K; Helm S; Birkenstock A; Hartung D
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():30-35. PubMed ID: 27528109
[TBL] [Abstract][Full Text] [Related]
6. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.
Stelzhammer V; Haenisch F; Chan MK; Cooper JD; Steiner J; Steeb H; Martins-de-Souza D; Rahmoune H; Guest PC; Bahn S
Int J Neuropsychopharmacol; 2014 Oct; 17(10):1599-608. PubMed ID: 24901538
[TBL] [Abstract][Full Text] [Related]
7. Th2 cytokine response in Major Depressive Disorder patients before treatment.
Pavón L; Sandoval-López G; Eugenia Hernández M; Loría F; Estrada I; Pérez M; Moreno J; Avila U; Leff P; Antón B; Heinze G
J Neuroimmunol; 2006 Mar; 172(1-2):156-65. PubMed ID: 16457895
[TBL] [Abstract][Full Text] [Related]
8. Targeting cytokines in reduction of depressive symptoms: A comprehensive review.
Shariq AS; Brietzke E; Rosenblat JD; Barendra V; Pan Z; McIntyre RS
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():86-91. PubMed ID: 29309829
[TBL] [Abstract][Full Text] [Related]
9. Association between abnormal serum myelin-specific protein levels and white matter integrity in first-episode and drug-naïve patients with major depressive disorder.
Jiang L; Cheng Y; Jiang H; Xu J; Lu J; Shen Z; Lu Y; Liu F; Li L; Xu X
J Affect Disord; 2018 May; 232():61-68. PubMed ID: 29477585
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory mechanisms in major depressive disorder.
Raedler TJ
Curr Opin Psychiatry; 2011 Nov; 24(6):519-25. PubMed ID: 21897249
[TBL] [Abstract][Full Text] [Related]
11. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
[TBL] [Abstract][Full Text] [Related]
12. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder.
Hoge EA; Brandstetter K; Moshier S; Pollack MH; Wong KK; Simon NM
Depress Anxiety; 2009; 26(5):447-55. PubMed ID: 19319993
[TBL] [Abstract][Full Text] [Related]
13. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression.
Zou W; Feng R; Yang Y
PLoS One; 2018; 13(6):e0197267. PubMed ID: 29856741
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder.
Hung YY; Huang KW; Kang HY; Huang GY; Huang TL
Psychopharmacology (Berl); 2016 May; 233(9):1707-14. PubMed ID: 26415953
[TBL] [Abstract][Full Text] [Related]
15. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
Köhler CA; Freitas TH; Maes M; de Andrade NQ; Liu CS; Fernandes BS; Stubbs B; Solmi M; Veronese N; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
Acta Psychiatr Scand; 2017 May; 135(5):373-387. PubMed ID: 28122130
[TBL] [Abstract][Full Text] [Related]
16. The Role of Cytokines in the Peripheral Blood of Major Depressive Patients.
Chen Y; Ouyang J; Liu S; Zhang S; Chen P; Jiang T
Clin Lab; 2017 Jul; 63(7):1207-1212. PubMed ID: 28792696
[TBL] [Abstract][Full Text] [Related]
17. T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression.
Huang TL; Lee CT
Psychiatry Clin Neurosci; 2007 Aug; 61(4):415-20. PubMed ID: 17610667
[TBL] [Abstract][Full Text] [Related]
18. An altered peripheral IL6 response in major depressive disorder.
Money KM; Olah Z; Korade Z; Garbett KA; Shelton RC; Mirnics K
Neurobiol Dis; 2016 May; 89():46-54. PubMed ID: 26804030
[TBL] [Abstract][Full Text] [Related]
19. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
Goldsmith DR; Rapaport MH; Miller BJ
Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
